埃布塞伦衍生物通过抑制其基本蛋白质来抑制SARS-CoV-2复制:PLPL
Mikolaj Zmudzinski1, Wioletta Rut2, Kamila Olech3
1Department of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wyb. Wyspianskiego 27, 50-370, Wroclaw, Poland. mikolaj.zmudzinski@pwr.edu.pl.
Scientific reports
|June 6, 2023
概括
埃布塞伦衍生物对SARS-CoV-2蛋白酶 (Mpro和PLpro) 和nsp14产生强大的抑制作用,为抗COVID-19的抗病毒疗法提供了一个有希望的新途径.
科学领域:
- 生物化学 生物化学
- 病毒学 病毒学
- 药用化学 医学化学
背景情况:
- 包括Mpro和PLpro在内的SARS-CoV-2蛋白酶对于病毒复制至关重要.
- 已知Ebselen是一种有机类药物,可以抑制这些蛋白酶.
- Nsp14的N7-甲基转移酶活性对于病毒RNA修饰至关重要.
研究的目的:
- 为了选EBSELEN衍生物以抑制SARS-CoV-2 Mpro和PLpro.
- 为了评估选定的化合物作为nsp14抑制剂.
- 评估ebselen类似物对SARS-CoV-2的抗病毒和细胞保护活性.
主要方法:
- 对34种ebselen和ebselen diselenide衍生物进行针对SARS-CoV-2 PLpro和Mpro.pro的查.
- 对蛋白酶抑制的酶检测.
- 对NSP14抑制的选定化合物的评估.
- 在Vero E6细胞中进行抗病毒和细胞保护性测试.
主要成果:
- 在ebselen衍生品中确定了强大的SARS-CoV-2PLpro和Mpro抑制剂,其中一些优于ebselen.
- 埃布塞伦衍生品也表明抑制了nsp14.
- 在基于细胞的测定中,Ebselen类似物表现出显著的抗病毒和细胞保护作用,细胞毒性较低.
结论:
- 埃布塞伦,其衍生品和迪塞利尼德类似物代表了开发针对SARS-CoV-2的新型抗病毒药物的有前途的治疗平台.
- 准病毒蛋白酶和nsp14为COVID-19治疗提供了一个可行的策略.
- 这些化合物的进一步开发可能会导致新的有效的抗SARS-CoV-2药物.
相关概念视频
Eukaryotic Transcription Inhibitors
9.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Enzyme Inhibition
78.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.8K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


